PureTech Health (PRTC) Gains from Investment Securities (2023 - 2025)

PureTech Health (PRTC) has 3 years of Gains from Investment Securities data on file, last reported at $3.7 million in Q2 2025.

• Gains from Investment Securities for Q2 2025 came in at $3.7 million, down 5.23% year-over-year; the trailing twelve-month figure through Jun 2025 was $19.3 million (changed N/A YoY), and the FY2025 annual result was -$38.5 million, down 194.13% from the prior year.
• Gains from Investment Securities fell to $3.7 million in Q2 2025 per PRTC's latest filing, from $3.9 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $7.8 million in Q4 2023 and troughed at $3.7 million in Q2 2025.
• A 3-year average of $4.8 million and a median of $3.9 million in 2024 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities slumped 50.35% in 2024, then fell 5.23% in 2025.
• A 3-year view of Gains from Investment Securities shows it stood at $7.8 million in 2023, then tumbled by 50.35% to $3.9 million in 2024, then dropped by 5.23% to $3.7 million in 2025.
• Business Quant data shows PRTC's Gains from Investment Securities at $3.7 million in Q2 2025, $3.9 million in Q4 2024, and $3.9 million in Q2 2024.